Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Severin Schwan
Age : 51
Public asset : 1,515,362 USD
Country of residence : Unknown
Linked companies : Roche Holding Ltd. - Credit Suisse Group AG

Summary 
Dr. Severin Schwan is a Member at European Round Table of Industrialists, a Member at International Business Leaders Advisory Council, Chairman at Roche Holdings, Inc., Chief Executive Officer at Roche Group, Chairman at Genentech, Inc. and Vice President at International Federation of Pharmaceutical Manufacturers A.

He was previously employed as Chief Executive Officer by Roche Diagnostics Corp., Head-Asia Pacific Region by Roche Diagnostics Asia Pacific Pte Ltd., Head-Global Finance & Services by Roche Diagnostics AG, Member-Executive Board by Roche Deutschland Holding GmbH, and Head-Finance & Administration by Roche (Brussels).

He also served on the board at Chugai Pharmaceutical Co., Ltd.

Dr. Schwan received his Master's degree in Economics and Law and a Doctor of Law degree from the University of Innsbruck.


Current positions of Severin Schwan 
NameTitle Since
Roche Holding Ltd.
(Pharmaceuticals)
Chief Executive Officer & Executive Director 2008
Credit Suisse Group AG
(Banks)
Independent Non-Executive Director 2014
Roche Group Chief Executive Officer 2008
Genentech, Inc. Chairman -
Roche Holdings, Inc. Chairman 2008
F. Hoffmann-La Roche Ltd. Chief Executive Officer & Director 1993
Credit Suisse AG Member of the Board of Directors 2014
Credit Suisse (Schweiz) AG Director 2015
International Federation of Pharmaceutical Manufacturers Vice President -
European Round Table of Industrialists Member 2013
International Business Leaders Advisory Council Member 2009


Holdings of Severin Schwan 
NameEquities%Valuation
Credit Suisse Group (CSGN)
Banks
84,8690.0033%1,639,681 USD


Severin Schwan : Personal Network 
NameLinked companies
Alan Hippe Roche Holding Ltd.
Genentech, Inc.
Roche Holdings, Inc.
Roche Group
John Irving Bell Roche Holding Ltd.
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
André S. Hoffmann Roche Holding Ltd.
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Paul Bulcke Roche Holding Ltd.
F. Hoffmann-La Roche Ltd.
European Round Table of Industrialists
Richard P. Lifton Roche Holding Ltd. (Bearer Share)
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Peter R. Voser Roche Holding Ltd.
F. Hoffmann-La Roche Ltd.
European Round Table of Industrialists
Julie Brown Roche Holding Ltd.
F. Hoffmann-La Roche Ltd.
Bernard J. Poussot Roche Holding Ltd.
F. Hoffmann-La Roche Ltd.
Christoph Franz Roche Holding Ltd. (Bearer Share)
F. Hoffmann-La Roche Ltd.
Andreas Oeri Roche Holding Ltd.
F. Hoffmann-La Roche Ltd.


Biography of Severin Schwan 
Severin Schwan (born 1967) is the CEO of the Roche group, a Swiss-founded, but now global pharmaceutical company.

Early life and career
Schwan serves as the Chief Executive Officer of F. Hoffmann-La Roche Ltd. Dr. Schwan serves as the Chief Executive Officer of Roche Diabetes Care AG. He has been the Group Chief Executive Officer of Roche Holding AG at Roche Pharma AG and Roche Pharmholding B.v. since March 2008. He serves as Chief Executive Officer of Roche Group. He served as the Group Chief Executive Officer of Roche Diagnostics Corporation, a Diagnostics Divisions of Roche Holding Ag since January 1, 2006. Dr. Schwan served as Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2006. He served as Trainee of Corporate Finance at Roche Basel from 1993 to 1995, Head Finance & Administration at Roche Brussels from 1995 to 1998, Head Finance & Informatics of Roche Grenzach and Member of the Executive Board of Roche Deutschland Holding GmbH from 1998 to 2000. He served as Head, Global Finance & Services of Roche Diagnostics from 2000 to 2004. He served as a Head of Diagnostics Asia-Pacific of Roche Holding Ag from 2004 to January 1, 2006. He served as Head of Global Finance & Services for the Diagnostics Division from 2000 to 2004. He served as a Director of Chugai Pharmaceutical Co. Ltd., and Genentech, Inc. He has been a Director of Roche Holdings, Inc. since April 29, 2008 and Roche Holding Ag 2013. Dr. Schwan holds Degree in Economics from University of Innsbruck, University of York and University of Oxford Mag. rer.soc.oec. (Innsbruck, 1991) and Law from University of Innsbruck Mag. iur. (Innsbruck, 1991) and Doctorate in Law from University of Innsbruck Research studies at University Louvain, Belgium Dr. iur. (Innsbruck, 1993).



Source @ Wikipedia



Most Read News 
02/16 WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
02/17 STEVE WYNN : Top Company News of the Day
02/15 PETER THIEL : Tech Luminary Peter Thiel Parts Ways With Silicon Valley
02/14 ROBIN LI : Baidu earnings beat forecasts, eyes U.S. listing for video unit iQiyi
02/16 ROMAN ABRAMOVICH : Co-owners of Russia's Nornickel back in fight for control
02/19 PETER THIEL : Top Company News of the Day
02/15 DAVID THOMSON : Thomson Reuters Chairman Criticized Its $17 Billion Deal with Blackstone
02/16 VINCENT BOLLORÉ : Vivendi shares drop as French group's lack of guidance underwhelms
02/17 THOMAS WILSON : Japan, short of workers, eyes hiking optional pension age beyond 70
02/19 OLEG DERIPASKA : Deripaska to Step Down as President of EN+ and Rusal -FT
More news


© 2018 People and Ownership :   
Advertisement
Severin Schwan : Connections 
Oxford Sciences Innovation Plc
Immunocore Ltd.
European Round Table of Industrialists
Oxagen Ltd.
Office for Strategic Co-ordination of Health Research
Nestlé Health Science SA
GMEC Management Co. Ltd.
New York Genome Center
Cargill, Inc.


Latest news about Severin Schwan 
02/01 U.S. tax change to help Roche's 2018 profit growth outpace sales
2017 Bumper crop of new drugs fails to lift big pharma R&D returns
2017 Merck raises stakes in lung cancer as rivals close in
2017 Roche study finds cancer 'Velcro' that halts T-cell attack
2017 Roche drug cocktail doubles chance of holding lung cancer at bay
2017 Roche to seize leap-frog opportunity in lung cancer
2017 ROCHE : 3Q Sales Increase on Strong Performance of Recently Launched Drugs
More news


Popular Business Leaders 
Bernard Arnault Jean-michel Aulas Jeff Bezos Kurt Bock Warren Buffett Jean-pierre Clamadieu Tim Cook Richard Cousins Elmar Degenhart Michael Dell Jamie Dimon Patrick Drahi Carlos Ghosn Stuart Gulliver David Henry Heinrich Hiesinger Carl Icahn Ingvar Kamprad Dara Khosrowshahi Isabelle Kocher Bruno Lafont Daniel Loeb Jack Ma Gérard Mestrallet Lakshmi Mittal Rupert Murdoch Elon Musk Michael O'leary Nelson Peltz Stefan Quandt Sumner Redstone Alexandre Ricard Stéphane Richard Kasper Rorsted Wilbur Ross Eric Schmidt George Soros Rupert Stadler Bernard Tapie Peter Terium Peter Thiel Patrick Thomas François Villeroy De Galhau Meg Whitman John Williamson Thomas Wilson Elaine Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders